Health Care & Life Sciences » Pharmaceuticals | Eagle Pharmaceuticals Inc.

Eagle Pharmaceuticals Inc.

Eagle Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 15.06 M
Public Float
 8.31 M
Eagle Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
 $2.56
Market Cap
 $838.51 M
Shares Outstanding
 14.86 M
Public Float
 12.81 M

Profile

Address
50 Tice Boulevard
Woodcliff Lake New Jersey 07677
United States
Employees -
Website http://www.eagleus.com
Updated 07/08/2019
Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban; ryanodex; docetaxel injection, non-alcohol formulation; and bendeka. The company was founded by Scott L.

Financials

View All
Created with Highcharts 5.0.14Eagle Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.6 0486 04822 02422 0242 5712 57181 45381 45351 94351 94331 90331 903201320142015201620172018020k40k60k80k100k
Created with Highcharts 5.0.14Eagle Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.13 67813 67822 40022 40066 22766 227189 482189 482236 707236 707213 312213 312201320142015201620172018050k100k150k200k250k

Michael Graves
Chairman
Scott L. Tarriff
Chief Executive Officer & Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.